Clinical Drug Experience Knowledgebase

autologous dendritic cells (2 trials)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (1 trial)

celecoxib (celebrex) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

dasatinib (sprycel) (1 trial)

doxorubicin (Doxil) (1 trial)

eribulin (halaven) (1 trial)

everolimus (zortress) (1 trial)

exemestane (aromasin) (2 trials)

ixabepilone (ixempra) (1 trial)

linseed oil (1 trial)

motesanib (1 trial)

niraparib (zejula) (1 trial)

paclitaxel (taxol) (3 trials)

pexidartinib (Turallo) (1 trial)

ritonavir (Norvir) (1 trial)

sargramostim (leukine) (1 trial)

seaweed (1 trial)

sitagliptin (januvia) (3 trials)

soy protein (1 trial)

thyrotropin releasing hormone (1 trial)

tigatuzumab (1 trial)

trastuzumab (herceptin) (5 trials)

trastuzumab emtansine (kadcyla) (1 trial)

veliparib (1 trial)

vinorelbine (navelbine) (2 trials)

vitamin d3 (1 trial)

avx901 (1 trial)

erlotinib (tarceva) (1 trial)

lapatinib (tykerb) (1 trial)

pertuzumab (perjeta) (2 trials)

trametinib (mekinist) (1 trial)

technetium tc-99m sestamibi (2 trials)